Children with chronic abdominal complaints are frequently referred to hospital, even though many can be managed appropriately in primary care. Fecal calprotectin (FCal) is a valuable test that helps general practitioners distinguish inflammatory bowel disease from non-inflammatory conditions.
This project develops and evaluates tailored implementation strategies to support guideline-based use of FCal testing. By improving diagnostic decision-making, we aim to reduce unnecessary referrals, lower the burden on children and families, and support sustainable implementation in daily practice.
We aim to identify implementation strategies that help general practitioners use FCal testing appropriately and consistently according to the NHG guideline. Ultimately, this should contribute to better diagnostic decision-making, more efficient use of healthcare resources, and improved patient experiences.
A meeting with all stakeholders was organized to discuss roles, responsibilities, and contributions within the project. In addition, the first interviews and focus group discussions have been completed.
University Medical Center Groningen (UMCG)
Department of Primary and Long-term Care
CALM
Internal postcode FA21
P.O. Box 196
9700 AD Groningen
UMCG
Department of Primary and Long-term Care
Oostersingel | entrance 47 | building 50 | 2nd floor
Groningen
The Netherlands
